40023-02-7 Usage
Uses
Used in Pharmaceutical Industry:
2-CHLORO-N-(3-METHOXYBENZYL)ACETAMIDE is used as a chemical intermediate for the synthesis of drugs, leveraging its structural components to contribute to the development of new medicinal compounds.
Used in Neurological and Psychiatric Treatments:
In the field of medicine, 2-CHLORO-N-(3-METHOXYBENZYL)ACETAMIDE is used as a potential therapeutic agent for neurological and psychiatric disorders, due to its demonstrated effects that could be beneficial in treating such conditions.
Used as an Anticonvulsant:
2-CHLORO-N-(3-METHOXYBENZYL)ACETAMIDE is utilized for its anticonvulsant properties, making it a candidate for the treatment of conditions that involve seizures or other convulsive activities.
Used as an Analgesic:
2-CHLORO-N-(3-METHOXYBENZYL)ACETAMIDE is also recognized for its analgesic properties, indicating its potential use in pain management and the development of pain-relief medications.
Check Digit Verification of cas no
The CAS Registry Mumber 40023-02-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,0,0,2 and 3 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 40023-02:
(7*4)+(6*0)+(5*0)+(4*2)+(3*3)+(2*0)+(1*2)=47
47 % 10 = 7
So 40023-02-7 is a valid CAS Registry Number.
InChI:InChI=1/C10H12ClNO2/c1-14-9-4-2-3-8(5-9)7-12-10(13)6-11/h2-5H,6-7H2,1H3,(H,12,13)
40023-02-7Relevant academic research and scientific papers
Probing structural requirements of positive allosteric modulators of the M4 muscarinic receptor
Huynh, Tracey,Valant, Celine,Crosby, Ian T.,Sexton, Patrick M.,Christopoulos, Arthur,Capuano, Ben
, p. 8196 - 8200 (2013/11/06)
The M4 mAChR is implicated in several CNS disorders and possesses an allosteric binding site for which ligands modulating the affinity and/or efficacy of ACh may be exploited for selective receptor targeting. We report the synthesis of a focused library of putative M4 PAMs derived from VU0152100 and VU10005. These compounds investigate the pharmacological effects of previously identified methoxy and fluoro substituents, providing useful estimates of affinity (KB), cooperativity (αβ), and direct agonist properties (τB).
